SIRP-γ Double Nickase Plasmid (h): sc-404902-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- SIRP-γ Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- SIRP-γ Double Nickase Plasmid (h) and SIRP-γ Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting SIRPG. One or both designs may be available
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: SIRP-γ Antibody (OX119): sc-53114
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SIRP-γ Double Nickase Plasmid (h) | sc-404902-NIC | 20 µg | $410.00 | |||
SIRP-γ Double Nickase Plasmid (h2) | sc-404902-NIC-2 | 20 µg | $410.00 |
SIRPG encodes signal regulatory protein gamma (SIRP-γ), an immunoglobulin superfamily receptor predominantly expressed on human T cells and other leukocyte subsets. Through binding to CD47, SIRP-γ participates in cell–cell recognition and immunological synapse organization, influencing leukocyte adhesion, migration, and activation programs. This axis intersects with pathways governing cytoskeletal remodeling and immune checkpoint-like signaling that shape tissue infiltration and inflammatory responses. Dysregulated CD47–SIRP family interactions and altered SIRPG expression patterns have been associated with tumor immune evasion contexts, autoimmunity-related immune imbalance, and graft-related immune reactivity, supporting its relevance in mechanistic immunology studies.
SIRP-γ Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the SIRPG locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within SIRPG. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt SIRPG function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of SIRPG-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.